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Abstract
The first crown ether-capped dibenzotetraaza[14]annulenes (DBTAAs), featuring two macrocyclic binding sites fixed in a face-to-
face orientation, were synthesized in satisfactory 26–28% isolated yields. Direct N-alkylation of 1,4,10-trioxa-7,13-diazacyclo-
pentadecane by symmetric DBTAA derivatives bearing bromoalkoxy pendants proceed smoothly at a reasonable level of dilution
(1.25 mM). The structures were fully characterized by HR-ESIMS, FTIR-ATR, 1H and 13C NMR spectroscopy and elemental anal-
ysis.
Introduction
The design and synthesis of novel polycyclic receptor architec-
ture is of fundamental importance, since model recognition
studies contribute to much better understanding of complex bio-
logical systems [1]. Since the serendipitous discovery of crown
ethers by Charles Pedersen in 1967 [2], there have been signifi-
cant advances in the design and synthesis of sophisticated
multidentate macrocycles with mixed-donor sites [3] and high
selectivity towards the cationic organic species [4] and ions of
certain metal elements [5]. Particulary, synthetic receptors
featuring crown ether moieties often equipped with extra side
arms bearing pendant functional groups [6,7], have attracted a
great deal of interest due to their outstanding binding ability and
offer promising applications in catalysis, bioinorganic,
biomimetic and analytic chemistry [8]. Polycyclic architecture
that incorporate crown ether moieties feature, confined space
capable of displaying fascinating properties, different from
those observed in bulk solution [9]. Therefore, the design and
synthesis of functionalized, cage-like architecture containing
converging binding sites arranged along the concave inner sur-
face is in high demand [10]. Nevertheless, synthetic access to
such a sophisticated polycyclic architecture is somewhat chal-
lenging and often requires the use of special techniques and
apparatuses [11]. Particularly, the crown ether-capped (or
‘crown-capped’) porphyrins are synthesized conventionally
under high-dilution conditions starting from two porphyrin
building blocks bearing complementary functionalities, such as
amine and either acyl chloride [12] or halomethyl [13], respec-
tively.
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Figure 1: Timeline for the structure evolution of crown-capped DBTAAs (created on the basis of references [24-28]).
The family of dibenzotetraaza[14]annulenes (abbreviated here-
after as DBTAAs) belong to a class of quadridentate Schiff base
macrocycles that display exceptional stability toward light,
oxygen and water [14]. Thanks to basic similarities in their
structure and physicochemical properties, DBTAAs emerged as
non-pyrrolic surrogates of porphyrins, and have become a
versatile platform for supramolecular [15], biomimetic [16,17],
biological [18,19] and material chemistry [20,21]. Although
much effort has been directed towards the study of crown ether-
capped porphyrins [22] and sapphyrines [23], little research has
been undertaken regarding DBTAAs functionalized with crown
ether moieties (see Figure 1).
Kruse and Breitmaier [24] reported annulated DBTAA‘s con-
taining benzo-15-crown-5 scaffolds fused with benzenoid rings
of the macrocyclic core. Both nickel(II) and cobalt(II) com-
plexes were prepared and their binding properties toward sodi-
um and potassium ions were studied in addition to transition
metals. Sakata et al. reported the syntheses and characterization
of nickel(II), copper(II) [25] and oxovanadium(IV) [26] com-
plexes of crown ether-annulated DBTAAs, which caused dimer-
ization in the presence of alkali metal and ammonium ions.
Sakata et al. reported the synthesis of peripherally functionali-
zed DBTAAs with the two benzo-15-crown-5 scaffolds
appended to the meso-benzoyl substituents [27]. Both crown
ether-capped macrocycles in a form of free base and nickel(II)
and cobalt(II) complexes showed cation and solvent-induced
dimerisation. More recently, Raston et al. reported the synthe-
sis of Goedken’s macrocycle tmtaa nickel(II) complex featuring
a single oligo(ethylene glycol) chain strapped across the face of
the DBTAA macrocyclic core [28]. However, to the best of our
knowledge, there are no reports on ‘crown-capped’ dibenzo-
tetraaza[14]annulenes.
Results and Discussion
Design principle and synthesis
To create polycyclic cage architecture, featuring two con-
verging binding sites, capable of simultaneous recognition and
cooperative binding of a variety of charged entities [29] or even
whole ion pairs within the same superstructure [30], we decided
to combine the two macrocyclic building blocks within the
same rigidified architecture. Therefore, novel ‘crown-capped’
receptors 3a and 3b were designed to be composed of diaza-
crown ether and DBTAA macrocycles. Arrangement of the two
macrocyclic components in a face-to-face orientation create a
central cavity lined by the two converging binding sites. We
decided to make use of the previously reported DBTAA deriva-
tives, bearing 3-bromopropoxy- [31] and 4-bromobutoxyben-
zoyl [32] pendants, since the presence of rigidifying benzoyl
substituents protect the central cavity from collapsing. Simulta-
neously, the use of short but flexible aliphatic chains as part of
the bridges make such receptors flexible enough to adjust the
size of the crown cavity to the dimension of the charged entity.
The new receptors 3a and 3b contain two apparently differenti-
ated Lewis-basic binding sites, however, from a broader
perspective, the nature of the DBTAA binding site can be easily
switched into a Lewis-acidic one after appropriate metal inser-
tion (e.g., with zinc(II) ions) [33].
The crown-capped DBTAA’s were synthesized by refluxing
1,4,10-trioxa-7,13-diazacyclopentadecane (1,7-diaza-15-crown-
5, kryptofix 21) with the previously reported bromoalkoxy
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Scheme 1: Synthesis of the crown-capped DBTAA receptors 3a and 3b. Reagents and conditions: i) Et3N, CH3CN, reflux, 24 h.
derivatives 2a and 2b in anhydrous acetonitrile containing an
excess of triethylamine for 24 hours (Scheme 1). The desired
crown ether-capped receptors 3a and 3b were isolated following
column chromatography as viscous oils in satisfactory 26–28%
isolated yields. The use of either mixtures of acetonitrile and
toluene (v:v, varied 4:1 to 1:4) as less polar reaction media did
not improve the overall yields despite extension of the reaction
time to 48 hours.
Spectral characterization
The new compounds 3a and 3b have been fully characterized
by FTIR-ATR, 1H and 13C NMR spectroscopy, high-resolution
electrospray ionization mass spectrometry (HR-ESIMS) and
elemental analysis, and the results are in agreement with ex-
pected structures (vide infra).
Both the crown ether-capped compounds 3a and 3b are highly
symmetrical as was evidenced by both the 1H and 13C NMR
spectra. The 13C NMR spectra of 3a and 3b display only one
characteristic resonance signal assignable to the carbonyl
moieties at δC ≈193 ppm. Simultaneously, macrocyclic inner
NH protons gave a well-resolved triplet at δH ≈14.4 ppm arising
from the coupling with the olefinic H–C=N protons (J ≈6.7 Hz),
observed as doublet at δH ≈8.6 ppm. Nevertheless, the most
intriguing feature of the 1H NMR spectra of the crown ether-
capped compounds 3a and 3b is the exceptionally large separa-
tion of proton resonance signals observed for the crown straps
of 3b (Figure 2a). 1H NMR spectra of both the N,N'-dimethyl
[34] and N,N'-dibenzyl [35] derivatives of 1,7-diaza-15-crown-
5, consist of two multiplets at δH 3.5–3.6 and 2.6–2.9 ppm, cor-
responding with oxo- and azaethylene proton resonances. Sur-
prisingly, crown ether ethylene proton resonances are
pronouncedly shifted downfield for the receptor 3b as com-
pared with the parent 1,7-diaza-15-crown-5 and the receptor 3a.
Although exact origin of such a difference needs to be further
evaluated, it seems reasonable that the contraction of the
bridging chains induces conformational changes that trigger
constraints into the benzoyl ring rotation. The fingerprint of the
oxoethylene proton resonances is composed of two triplets at
δH 3.38 and 3.17 ppm and intense singlet at 3.43 ppm. At the
same time, the fingerprint of the azaethylene proton resonances
is composed of two triplets at δH 2.53 and 2.45 ppm; the latter
is partially overlapped with proton resonances of aliphatic
bridges. Receptor 3b displays the properties of chemical shift
reagents, similar to the previously reported crown ether-capped
porphyrin [36] but of different origin.
Since, the macrocyclic dibenzotetraaza[14]annulene core is
antiaromatic, and shows no diamagnetic ring current character-
istic for porphyrins, the remarkable chemical shift differentia-
tion observed for the crown strap shall be rationalized by its
close spatial proximity to anisotropy cones spanning from aro-
matic substituent’s.
Moreover, vicinal coupling constants 3JH-H found for the crown
ethylene bridges fall within the range of 5.4–5.5 Hz, expected
for gauche stereochemistry. Such a relaxed crown conforma-
tion is suitable for accommodation of large alkali and alkaline-
earth cations.
The general features of FTIR-ATR spectra of receptors 3a and
3b are substantially similar to each other and almost undistin-
guishable from that of the corresponding parent α,ω-dibro-
moalkoxy-derivatives 2a and 2b. Slightly higher intensities are
observed for absorption bands attributed to both the C–H
(2924–2857 cm−1) and C–O–C (1246–1044 cm−1) stretching
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Figure 2: 1H NMR spectra (298 K, CDCl3) of: a) crown ether-capped receptor 3b and b) it’s corresponding parent 1,7-diaza-15-crown-5. The insets
show an enlarged portion of 1H NMR spectra showing signals attributed to the crown ether ethylene protons.
vibrations. The presence of strong absorption bands at ca. 1590
and 1560 cm−1, assignable to the olefinic and imine skeletal
stretching modes, implies the macrocyclic scaffold integrity.
The FTIR-ATR spectra consist also with the characteristic, but
modest in intensity, the absorption band at ca. 1646 cm−1 attrib-
utable to the carbonyl moiety stretching vibrations.
The HR-ESIMS (positive ion mode) spectra of crown ether-
capped DBTAA‘s 3a and 3b revealed base peaks of the pseudo-
molecular ions [M + H]+ at m/z 855.4467 and 827.4135, respec-
tively, that are in a very good agreement with the theoretical
isotopic distribution patterns.
Conclusion
Creation of polycyclic architectures predisposed to perform
higher forms of molecular behaviour is essential for advancing
the art of biomimetic chemistry. Therefore, the first crown
ether-capped DBTAAs, featuring a face-to-face arrangement of
the macrocyclic components, have been synthesized in satisfac-
tory 26–28% isolated yields and fully characterized based on
HR-ESIMS, FTIR-ATR, 1H and 13C NMR spectroscopy and
elemental analysis. These novel receptors are expected to bind
both the transition, alkali and alkaline-earth metals, and also,
after DBTAA subunit metalation the whole ion pairs. The
binding properties of the crown ether-capped DBTAA recep-
tors are under investigation and will be reported elsewhere.
Experimental
General procedure for the synthesis of crown
ether-capped DBTAA’s 3a and 3b
1,7-Diaza-15-crown-5 (0.1 mmol, 22 mg) together with triethyl-
amine (0.05 mL) was added to a suspension of appropriate α,ω-
dibromoalkoxy macrocyclic derivative 2a or 2b (0.1 mmol) in
80 mL of anhydrous acetonitrile and stirred under reflux for
24 h. In due course, the orange precipitate gradually disap-
peared and a clear red solution was obtained. Afterwards, the
reaction mixture was evaporated to dryness under reduced pres-
sure and the crude residue was taken up in 20 mL of chloro-
form and washed with distilled water (2 × 50 mL). The organic
phase was dried over anhydrous MgSO4, filtered through a
glass filter, concentrated to a minimal volume and applied
directly onto the top of a silicagel column equilibrated with
chloroform. The column was firstly eluted isocratically with a
mixture of chloroform and acetone (1:1, v/v) to remove any
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unreacted traces of α,ω-dibromoalkoxy macrocyclic derivatives
2a or 2b. The second band containing undesired site products
was eluted isocratically with a mixture of chloroform and meth-
anol (1:1, v/v). The third, main band, was eluted isocratically
with a mixture of CHCl3/MeOH/NH3aq (10:10:1, v/v/v), evapo-
rated to dryness under reduced pressure, and kept in a vacuum
overnight at ambient temperature to remove all volatiles.
Crown ether-capped DBTAA macrocycle 3a: [7,16-{2,2'-
[7,13-bis(3-propyloxy)-1,4,10-trioxa-7,13-diazacyclopenta-
decane]dibenzoyl}-5,14-dihydrodibenzo[b,i][1,4,8,11]-
tetraazacyclotetradecine]: Orange oil. Isolated yield 26.1%
(26 mg). 1H NMR (300 MHz, CDCl3, TMS, 298 K) δ 1.49 (m,
4H, CH2), 1.68 (m, 4H, CH2), 2.44 (m, 8H, NCH2), 2.53 (t, 
3J =
5.4 Hz, 4H, NCH2), 3.17 (t, 
3J = 5.5 Hz, 4H, OCH2), 3.38 (t,
3J = 5.4 Hz, 4H, OCH2), 3.43 (s, 4H, OCH2), 4.05 (t, 
3J = 5.6
Hz, 4H, CH2), 6.98–7.18 (m, 12H, H-3’,5’,3,4,5,6), 7.35 (dd,
4J = 1.7 Hz, 3J = 7.5 Hz, 2H, H-6’), 7.43 (ddd, 4J = 1.8 Hz, 3J =
7.4 Hz, 3J = 8.4 Hz, 2H, H-4’), 8.59 (d, 3J = 6.4 Hz, 4H, N=C-
H), 14.44 (t, 3J = 6.6 Hz, 2H, NH); 13C{1H} NMR (75 MHz,
CDCl3, TMS, 298 K) δ 23.68, 27.31, 53.35, 54.89, 56.25,
68.57, 70.03, 70.38, 110.44, 111.92, 115.58, 121.11, 126.49,
129.29, 129.45, 131.18, 137.23, 153.10, 155.55, 192.97 (C=O);
FTIR (ATR) ν: 3069 (C=C), 2925 (C-H), 2857 (C-H), 1646
(C=O), 1589 (C=N), 1560 (C=C), 1488, 1446, 1286, 1246
(COC), 1137, 1102, 1044 (COC), 908, 822, 745, 660 cm−1;
HR-ESIMS (+νe mode) m/z (%): [M + H]+ calcd for
C50H59N6O7, 855.4445; found, 855.4467 (100), Δm = 2.2 ppm;
anal. calcd for C50H58N6O7·0.5CHCl3: C, 66.31; H, 6.45; N,
9.19; found: C, 66.16; H, 6.58; N, 9.02.
Crown ether-capped DBTAA macrocycle 3b: [7,16-{2,2'-
[7,13-bis(4-butyloxy)-1,4,10-trioxa-7,13-diazacyclopenta-
decane]dibenzoyl}-5,14-dihydrodibenzo[b,i][1,4,8,11]tetra-
azacyclotetradecine]: Red oil. Isolated yield 28.7% (16 mg).
1H NMR (300 MHz, CDCl3, TMS, 298 K) δ 1.82 (m, 4H,
CH2), 2.53 (m, 12H, NCH2), 3.25 (t, 
3J = 5.3 Hz, 4H, OCH2),
3.46 (s, 4H, OCH2), 3.47 (t, 
3J = 4.8 Hz, 4H, OCH2), 4.03 (t,
3J = 5.3 Hz, 4H, CH2), 6.97–7.18 (m, 12H, H-3’,5’,3,4,5,6),
7.41–7.47 (m, 4H, H-4’,6’), 8.59 (d, 3J = 6.7 Hz, 4H, N=C-H),
14.44 (t, 3J = 6.7 Hz, 2H, NH); 13C{1H} NMR (75 MHz,
CDCl3, TMS, 298 K) δ 26.90, 52.85, 53.87, 54.42, 66.51,
68.43, 70.09, 70.29, 110.56, 111.75, 115.07, 121.33, 126.39,
129.44, 129.83, 131.44, 136.83, 152.52, 155.40, 192.79 (C=O);
FTIR (ATR) ν: 3069 (C=C), 2924 (C-H), 2862 (C-H), 1647
(C=O), 1589 (C=N), 1562 (C=C), 1489, 1449, 1287, 1247
(COC), 1139, 1101, 1045 (COC), 908, 823, 742 cm−1;
HR-ESIMS (+νe mode) m/z (%): [M + H]+ calcd for
C48H55N6O7, 827.4132; found, 827.4135 (100), Δm = 0.3 ppm;
anal. calcd for C48H54N6O7
.CH2Cl2: C, 64.54; H, 6.19; N, 9.22;
found: C, 64.81; H, 6.32; N, 8.85.
Supporting Information
Supporting Information File 1
Detailed descriptions of experimental methods and copies
of original FTIR-ATR, HR-ESIMS, 1H and 13C NMR
spectra for all new compounds.
[https://www.beilstein-journals.org/bjoc/content/
supplementary/1860-5397-15-57-S1.pdf]
Acknowledgements
Financial support from the Polish Ministry of Science and
Higher Education (Project NN204165236) is gratefully ac-
knowledged.
ORCID® iDs
Krzysztof M. Zwoliński - https://orcid.org/0000-0002-8104-6670
Julita Eilmes - https://orcid.org/0000-0003-3905-149X
References
1. Lehn, J.-M. Supramolecular Chemistry – Concepts and Perspectives;
VCH: Weinheim, Germany, 1995. doi:10.1002/3527607439
2. Pedersen, C. J. J. Am. Chem. Soc. 1967, 89, 2495–2496.
doi:10.1021/ja00986a052
3. Izatt, R. M.; Christensen, J. K., Eds. Synthetic Multidentate Macrocyclic
Compounds; Academic Press, Inc.: New York, 1978.
4. Späth, A.; König, B. Beilstein J. Org. Chem. 2010, 6, No. 32.
doi:10.3762/bjoc.6.32
5. Arduini, A.; Casnati, A.; Pochini, A.; Ungaro, R. Curr. Opin. Chem. Biol.
1997, 1, 467–474. doi:10.1016/s1367-5931(97)80040-3
6. Stadlbauer, S.; Riechers, A.; Späth, A.; König, B. Chem. – Eur. J.
2008, 14, 2536–2541. doi:10.1002/chem.200701442
7. Späth, A.; König, B. Tetrahedron 2010, 66, 1859–1873.
doi:10.1016/j.tet.2010.01.028
8. Gokel, G. Crown Ethers and Cryptands; Royal Society of Chemistry:
Cambridge, U. K., 1991.
9. Jiou, J.; Chiravuri, K.; Gudapati, A.; Gassensmith, J. J.
Curr. Org. Chem. 2014, 18, 2002–2009.
doi:10.2174/1385272819666140514005254
10. Kubik, S. Top. Curr. Chem. 2012, 319, 1–34.
doi:10.1007/128_2011_244
11. Rossa, L.; Vögtle, F. Top. Curr. Chem. 1983, 113, 1–86.
doi:10.1007/3-540-12397-0_1
12. Collman, J. P.; Zhang, X.; Herrmann, P. C.; Uffelman, E. S.; Boitrel, B.;
Straumanis, A.; Brauman, J. I. J. Am. Chem. Soc. 1994, 116,
2681–2682. doi:10.1021/ja00085a083
13. Comte, C.; Gros, C. P.; Koeller, S.; Guilard, R.; Nurco, D. J.;
Smith, K. M. New J. Chem. 1998, 22, 621–626. doi:10.1039/a709181h
14. Mountford, P. Chem. Soc. Rev. 1998, 27, 105–116.
doi:10.1039/a827105z
15. Pawlica, D.; Marszałek, M.; Mynarczuk, G.; Sieroń, L.; Eilmes, J.
New J. Chem. 2004, 28, 1615–1621. doi:10.1039/b409298h
16. Paschke, J.; Kirsch, M.; Korth, H.-G.; de Groot, H.; Sustmann, R.
J. Am. Chem. Soc. 2001, 123, 11099–11100. doi:10.1021/ja015544v
Beilstein J. Org. Chem. 2019, 15, 617–622.
622
17. Sustmann, R.; Korth, H.-G.; Kobus, D.; Baute, J.; Seiffert, K.-H.;
Verheggen, E.; Bill, E.; Kirsch, M.; de Groot, H. Inorg. Chem. 2007, 46,
11416–11430. doi:10.1021/ic700961b
18. Bončina, M.; Podlipnik, Č.; Piantanida, I.; Eilmes, J.;
Teulade-Fichou, M.-P.; Vesnaver, G.; Lah, J. Nucleic Acids Res. 2015,
43, 10376–10386. doi:10.1093/nar/gkv1167
19. Radić-Stojković, M.; Marjanović, M.; Pawlica, D.; Dudek, Ł.; Eilmes, J.;
Kralj, M.; Piantanida, I. New J. Chem. 2010, 34, 500–507.
doi:10.1039/b9nj00490d
20. Grolik, J.; Sieroń, L.; Eilmes, J. Tetrahedron Lett. 2006, 47,
8209–8213. doi:10.1016/j.tetlet.2006.09.134
21. Paquette, J. A.; Gilroy, J. B. J. Polym. Sci., Part A: Polym. Chem. 2016,
54, 3257–3266. doi:10.1002/pola.28211
22. Even, P.; Boitrel, B. Coord. Chem. Rev. 2006, 250, 519–541.
doi:10.1016/j.ccr.2005.09.003
23. Sessler, J. L.; Brucker, E. A. Tetrahedron Lett. 1995, 36, 1175–1176.
doi:10.1016/0040-4039(94)02490-3
24. Kruse, R.; Breitmaier, E. Chem. Ber. 1981, 114, 832–836.
doi:10.1002/cber.19811140246
25. Sakata, K.; Annoura, T. Inorg. Chim. Acta 1990, 176, 123–129.
doi:10.1016/s0020-1693(00)85102-6
26. Sakata, K.; Kawano, T.; Annoura, T.
Synth. React. Inorg. Met.-Org. Chem. 1994, 24, 905–912.
doi:10.1080/00945719408001310
27. Sakata, K.; Shimoda, M.; Hashimoto, M. J. Heterocycl. Chem. 1996,
33, 1593–1598. doi:10.1002/jhet.5570330607
28. Hardie, M. J.; Malic, N.; Nichols, P. J.; Raston, C. L. Tetrahedron Lett.
2001, 42, 8075–8079. doi:10.1016/s0040-4039(01)01704-x
29. Kobuke, Y.; Kokubo, K.; Munakata, M. J. Am. Chem. Soc. 1995, 117,
12751–12758. doi:10.1021/ja00156a012
30. Kubik, S.; Goddard, R. J. Org. Chem. 1999, 64, 9475–9486.
doi:10.1021/jo991087d
31. Dudek, Ł.; Grolik, J.; Kaźmierska, A.; Szneler, E.; Eilmes, A.;
Stadnicka, K.; Eilmes, J. Tetrahedron Lett. 2011, 52, 3597–3601.
doi:10.1016/j.tetlet.2011.05.008
32. Pawlica, D.; Radić-Stojković, M.; Dudek, Ł.; Piantanida, I.; Sieroń, L.;
Eilmes, J. Tetrahedron 2009, 65, 3980–3989.
doi:10.1016/j.tet.2009.03.030
33. Geduhn, J.; Walenzyk, T.; König, B. Curr. Org. Synth. 2007, 4,
390–412. doi:10.2174/157017907782408770
34. Solov'ev, V. P.; Strakhova, N. N.; Kazachenko, V. P.; Solotnov, A. F.;
Baulin, V. E.; Raevsky, O. A.; Rüdiger, V.; Eblinger, F.;
Schneider, H.-J. Eur. J. Org. Chem. 1998, 1379–1389.
doi:10.1002/(sici)1099-0690(199807)1998:7<1379::aid-ejoc1379>3.0.c
o;2-9
35. Gatto, V. J.; Arnold, K. A.; Viscariello, A. M.; Miller, S. R.;
Morgan, C. R.; Gokel, G. W. J. Org. Chem. 1986, 51, 5373–5384.
doi:10.1021/jo00376a059
36. Chang, C. K. J. Am. Chem. Soc. 1977, 99, 2819–2822.
doi:10.1021/ja00450a080
License and Terms
This is an Open Access article under the terms of the
Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0). Please note
that the reuse, redistribution and reproduction in particular
requires that the authors and source are credited.
The license is subject to the Beilstein Journal of Organic
Chemistry terms and conditions:
(https://www.beilstein-journals.org/bjoc)
The definitive version of this article is the electronic one
which can be found at:
doi:10.3762/bjoc.15.57
